Literature DB >> 23154461

Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis.

Raquel Herrero1, Elena Garcia-Martin, Carmen Almarcegui, Jose R Ara, Diego Rodriguez-Mena, Jesus Martin, Sofia Otin, Maria Satue, Luis E Pablo, Francisco J Fernandez.   

Abstract

PURPOSE: To quantify changes in the retinal nerve fiber layer (RNFL) of patients with multiple sclerosis (MS) over 3 years and to evaluate whether treatment protects against RNFL degeneration.
METHODS: Ninety-four MS patients and 50 healthy subjects were followed-up over 3 years. All subjects underwent a complete ophthalmic examination, which included assessment of visual acuity (Snellen chart), color vision (Ishihara pseudoisochromatic plates), visual field examination, optical coherence tomography (OCT), and visual evoked potentials (VEPs). All patients were reevaluated at 12, 24, and 36 months to quantify changes in the RNFL.
RESULTS: Changes were detected in RNFL thickness at the 36-month follow-up. Significant decreases (P < 0.05, t-test) were observed in the mean, superior, inferior, and temporal RNFL thicknesses, and macular volume provided by OCT, and in the P100 latency of VEP of the MS group, but only in the mean and inferior RNFL thicknesses of the healthy control group. Greater changes in the superior and inferior RNFL thicknesses during follow-up were detected in the MS group. Differences between treatments were not detected, but untreated patients had higher degeneration in the mean and superior RNFL thicknesses during the follow-up (P = 0.040 and P = 0.19, respectively).
CONCLUSIONS: Progressive axonal loss can be detected in the optic nerve fiber layer of MS patients. Analysis of the RNFL by OCT can be useful for evaluating MS progression and efficacy of treatment as a neuroprotective factor against axonal degeneration.

Entities:  

Mesh:

Year:  2012        PMID: 23154461     DOI: 10.1167/iovs.12-10362

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Analysis of multiple sclerosis patients with electrophysiological and structural tests.

Authors:  Mualla Hamurcu; Gürdal Orhan; Murat Sinan Sarıcaoğlu; Semra Mungan; Zeynep Duru
Journal:  Int Ophthalmol       Date:  2016-08-18       Impact factor: 2.031

2.  Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis without Optic Neuritis: A 20-Month Longitudinal Study.

Authors:  Nergiz Huseyinoglu; Serkan Ozben; Metin Ekinci; Cagatay Buyukuysal; Murat Yıldırım; Hilal Safak; Halil Huseyin
Journal:  Neuroophthalmology       Date:  2013-05-31

3.  Decreased Ocular Pulse Amplitude and Retinal Nerve Fibre Layer in Multiple Sclerosis.

Authors:  Ebru N Cetin; Cagdas Erdogan; Semra Acer; Gülden Sarac; Cem Yıldırım; Levent S Bir
Journal:  Neuroophthalmology       Date:  2013-05-31

4.  Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Authors:  Antonio Barreiro-González; Maria T Sanz; Sara Carratalà-Boscà; Francisco Pérez-Miralles; Carmen Alcalá; Enrique España-Gregori; Bonaventura Casanova
Journal:  Acta Neurol Belg       Date:  2020-10-12       Impact factor: 2.396

Review 5.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

6.  Ability of swept source OCT to detect retinal changes in patients with bipolar disorder.

Authors:  Vicente Polo; Maria Satue; Alicia Gavin; Elisa Vilades; Elvira Orduna; Marta Cipres; Javier Garcia-Campayo; Mayte Navarro-Gil; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin
Journal:  Eye (Lond)       Date:  2018-10-31       Impact factor: 3.775

7.  No significant retinal damage induced by major orthopedic surgery - a pilot study.

Authors:  Tomas Parizek; Roman Skulec; Ivana Liehneova; Petr Prasek; Vladimir Cerny
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-04-19       Impact factor: 1.245

Review 8.  Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditions.

Authors:  T J MacGillivray; E Trucco; J R Cameron; B Dhillon; J G Houston; E J R van Beek
Journal:  Br J Radiol       Date:  2014-06-17       Impact factor: 3.039

9.  Genetic variation affects morphological retinal phenotypes extracted from UK Biobank optical coherence tomography images.

Authors:  Hannah Currant; Pirro Hysi; Tomas W Fitzgerald; Puya Gharahkhani; Pieter W M Bonnemaijer; Anne Senabouth; Alex W Hewitt; Denize Atan; Tin Aung; Jason Charng; Hélène Choquet; Jamie Craig; Peng T Khaw; Caroline C W Klaver; Michiaki Kubo; Jue-Sheng Ong; Louis R Pasquale; Charles A Reisman; Maciej Daniszewski; Joseph E Powell; Alice Pébay; Mark J Simcoe; Alberta A H J Thiadens; Cornelia M van Duijn; Seyhan Yazar; Eric Jorgenson; Stuart MacGregor; Chris J Hammond; David A Mackey; Janey L Wiggs; Paul J Foster; Praveen J Patel; Ewan Birney; Anthony P Khawaja
Journal:  PLoS Genet       Date:  2021-05-12       Impact factor: 5.917

10.  Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up.

Authors:  Riwanti Estiasari; Adisresti Diwyacitta; Muhammad Sidik; Ni Nengah Rida Ariarini; Freddy Sitorus; Saraf Shafa Marwadhani; Kartika Maharani; Darma Imran; Reza Aditya Arpandy; David Pangeran; Manfaluthy Hakim
Journal:  Neurol Res Int       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.